PMID- 27516392 OWN - NLM STAT- MEDLINE DCOM- 20171016 LR - 20211204 IS - 1527-6473 (Electronic) IS - 1527-6465 (Linking) VI - 23 IP - 1 DP - 2017 Jan TI - Impact of donor-recipient genetic relationship on outcome of living donor liver transplantation. PG - 43-49 LID - 10.1002/lt.24599 [doi] AB - Living donor liver transplantation (LDLT) is a valuable option for expanding the donor pool, especially in localities where deceased organ harvesting is not allowed. In addition, rejection rates were found to be lower in LDLT, which is attributed to the fact that LDLT is usually performed between relatives. However, the impact of genetic relation on the outcome of LDLT has not been studied. In this study, we examined the difference in rejection rates between LDLT from genetically related (GR) donors and genetically unrelated (GUR) donors. All cases that underwent LDLT during the period from May 2004 until May 2014 were included in the study. The study group was divided into 2 groups: LDLT from GR donors and LDLT from GUR donors. A total of 308 patients were included in the study: 212 from GR donors and 96 from GUR donors. Human leukocyte antigen (HLA) typing was not included in the workup for matching donors and recipients. GUR donors were wives (36; 11.7%), sons-in-law (7; 2.3%), brothers-in-law (12; 3.9%), sisters-in-law (1; 0.3%), and unrelated (38; 12.3%). The incidence of acute rejection in the GR group was 17.4% and 26.3% in the GUR group (P value = 0.07). However, there was a significant difference in the incidence of chronic rejection (CR) between the 2 groups: 7% in GR group and 14.7% in the GUR group (P value = 0.03). In terms of overall survival, there was no significant difference between both groups. LDLT from the GUR donors is not associated with a higher incidence of acute cellular rejection. However, CR was significantly lower when grafts were procured from GR donors. HLA matching may be recommended before LDLT from GUR donors. Liver Transplantation 23:43-49 2017 AASLD. CI - (c) 2016 by the American Association for the Study of Liver Diseases. FAU - Ali, Mahmoud Abdelwahab AU - Ali MA AUID- ORCID: 0000-0001-7958-4202 AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Elshobari, Mohamed Morsi AU - Elshobari MM AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Salah, Tarek AU - Salah T AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Kandeel, Al-Refaey AU - Kandeel AR AD - Anesthesia and Intensive Care Department, Mansoura University, Mansoura City, Egypt. FAU - Sultan, Ahmad Mohammad AU - Sultan AM AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Elghawalby, Ahmad Nabieh AU - Elghawalby AN AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Shehta, Ahmed AU - Shehta A AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Elsayed, Usama AU - Elsayed U AD - Anesthesia and Intensive Care Department, Mansoura University, Mansoura City, Egypt. FAU - Fathy, Omar AU - Fathy O AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. FAU - Yassen, Amr AU - Yassen A AUID- ORCID: 0000-0001-6607-7877 AD - Anesthesia and Intensive Care Department, Mansoura University, Mansoura City, Egypt. FAU - Wahab, Mohamed Abdel AU - Wahab MA AD - Liver Transplantation Unit, Gastroenterology Surgical Center, Mansoura University, Mansoura City, Egypt. LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Liver Transpl JT - Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society JID - 100909185 RN - 0 (HLA Antigens) SB - IM MH - Adult MH - End Stage Liver Disease/mortality/*surgery MH - Female MH - Graft Rejection/*epidemiology/genetics/immunology/prevention & control MH - Graft Survival/*genetics/immunology MH - HLA Antigens/analysis MH - Hepacivirus/isolation & purification MH - Histocompatibility Testing MH - Humans MH - Immunosuppression Therapy/methods MH - Incidence MH - Kaplan-Meier Estimate MH - Liver Transplantation/*methods MH - *Living Donors MH - Male MH - Middle Aged MH - Perioperative Period/mortality MH - Retrospective Studies MH - Severity of Illness Index MH - Tissue and Organ Harvesting/legislation & jurisprudence/*methods MH - Transplant Recipients MH - Treatment Outcome MH - Unrelated Donors EDAT- 2016/08/16 06:00 MHDA- 2017/10/17 06:00 CRDT- 2016/08/13 06:00 PHST- 2016/04/13 00:00 [received] PHST- 2016/07/28 00:00 [accepted] PHST- 2016/08/16 06:00 [pubmed] PHST- 2017/10/17 06:00 [medline] PHST- 2016/08/13 06:00 [entrez] AID - 10.1002/lt.24599 [doi] PST - ppublish SO - Liver Transpl. 2017 Jan;23(1):43-49. doi: 10.1002/lt.24599.